Cargando…
Novel peptides derived from neuropeptide Y prevent chemotherapy-induced bone marrow damage by regulating hematopoietic stem cell microenvironment
Chemotherapy-induced bone marrow damage is accompanied by acute nerve injury in the bone marrow (BM), resulting in sensory and autonomic neuropathy. Cisplatin, a popular chemotherapy drugs, induces the impairment of hematopoietic stem cells (HSCs) and bone marrow regeneration, leading to chronic bon...
Autores principales: | Park, Min Hee, Baek, Bosung, Jin, Hee Kyung, Bae, Jae-sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171453/ https://www.ncbi.nlm.nih.gov/pubmed/30460109 http://dx.doi.org/10.1080/19768354.2018.1517826 |
Ejemplares similares
-
Role of neuropeptide Y in the bone marrow hematopoietic stem cell microenvironment
por: Park, Min Hee, et al.
Publicado: (2015) -
Neuropeptide Y-based recombinant peptides ameliorate bone loss in mice by regulating hematopoietic stem/progenitor cell mobilization
por: Park, Min Hee, et al.
Publicado: (2017) -
Neuropeptide Y improves cisplatin-induced bone marrow dysfunction without blocking chemotherapeutic efficacy in a cancer mouse model
por: Park, Min Hee, et al.
Publicado: (2017) -
Bone marrow adipocytes as negative regulators of the hematopoietic microenvironment
por: Naveiras, Olaia, et al.
Publicado: (2009) -
The Bone Marrow Microenvironment as Niche Retreats for Hematopoietic and Leukemic Stem Cells
por: Nwajei, Felix, et al.
Publicado: (2013)